Xcout Intel
Clinical Laserthermia Syst. B
Clinical Laserthermia Systems develops minimally invasive laser ablation systems and thermal therapy products for use in oncology, urology, and neurosurgery. The company serves healthcare professionals and hospitals by providing tools for precise tissue ablation in treatments such as localized prostate cancer and brain lesions.
Subscribe to see Clinical Laserthermia Syst. B’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Clinical Laserthermia Syst. B at a glance
Clinical Laserthermia Syst. B is a health care company headquartered in Sweden. Xcout tracks 5 named people at Clinical Laserthermia Syst. B, including Peter Max (Chairman of the Board).
Clinical Laserthermia Syst. B leadership
- Peter MaxChairman of the Board
- Jerker NygrenMember of the Board
- Lena HöglundMember of the Board
- Thomas BinzerMember of the Board
- Veronica Byfield SköldMember of the Board
Clinical Laserthermia Syst. B competitors
A few of Clinical Laserthermia Syst. B's closest competitors — see the full list of competitors and alternatives →
Nexstim Oyj develops and provides medical technology systems, specifically navigated Transcranial Magnetic Stimulation (nTMS) equipment such as the NBS 6 system. Its products are utilized by healthcare professionals for diagnostics, brain mapping in neurosurgery, and the treatment of conditions like depression and chronic pain.
CollimateHealth is a Munich-based oncology technology startup and life sciences company. It is developing a clinically scalable microbeam radiation technology for oncological treatment, aiming to transform radiation therapy into an immunotherapy. The company recently closed an oversubscribed €6 million seed round.
Leo Cancer Care is a medical technology company headquartered in Crawley, Surrey, focused on improving cancer treatment through upright patient positioning and advanced radiation therapy.
C. Light Technologies is a U.S. healthcare technology company developing noninvasive, high-precision eye-tracking systems that measure eye movements as biomarkers of neurological health. Its technology is intended for clinicians and researchers studying or assessing conditions such as multiple sclerosis and other neurologic disorders.
Scandinavian ChemoTech AB develops and markets medical technology products for tumor treatment in humans and animals. Its proprietary Tumour Specific Electroporation (TSE) platform and IQwave system use targeted electric pulses to enhance the efficacy of low-dose chemotherapy while preserving healthy tissue.
Advanced Particle Therapy develops, builds, and manages proton therapy cancer treatment centers for academic medical institutions and healthcare systems. The company provides turnkey development solutions, including facility design and construction, equipment planning, financing, and operational management.
Get Clinical Laserthermia Syst. B's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Clinical Laserthermia Syst. B in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access